Report copyright - AVIS D’EFFICIENCE GAZYVARO™ 1000 mg (Obinutuzumab) · 2019-04-08 · GAZYVAROTM (Obinutuzumab) – Avis d’efficience HAS / Service évaluation économique et santé publique
Please pass captcha verification before submit form
Please pass captcha verification before submit form